Home » Trials » SLCTR/2020/026 » Progress Reports


Trials - SLCTR/2020/026

Progress Report

Date Modified

2021-06-29


Period

6/months


Report Summary

• Number assessed for eligibility: 134 • Number recruited and allocated/randomized: 111 • Final sample size: 111 • The recruitment of patients was suspended because the vast majority were arriving already vaccinated against Covid-19. We are beginning the data analysis and the follow-up of sequelae in the patients has yet to be completed in the next four months.


Attached file